|
1
|
He J, Gu D, Wu X, et al: Major causes of
death among men and women in China. N Engl J Med. 353:1124–1134.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Llovet JM, Ricci S, Mazzaferro V, Hilgard
P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A,
et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J
Med. 359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakamizo A, Marini F, Amano T, Khan A,
Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, et
al: Human bone marrow-derived mesenchymal stem cells in the
treatment of gliomas. Cancer Res. 65:3307–3318. 2005.PubMed/NCBI
|
|
5
|
Aboody KS, Brown A, Rainov NG, Bower KA,
Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, et al:
Neural stem cells display extensive tropism for pathology in adult
brain: Evidence from intracranial gliomas. Proc Natl Acad Sci U S
A. 97:12846–12851. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen X, Lin X, Zhao J, Shi W, Zhang H,
Wang Y, Kan B, Du L, Wang B, Wei Y, et al: A tumor-selective
biotherapy with prolonged impact on established metastases based on
cytokine gene-engineered MSCs. Mol Ther. 16:749–756. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Uchibori R, Okada T, Ito T, Urabe M,
Mizukami H, Kume A and Ozawa K: Retroviral vector-producing
mesenchymal stem cells for targeted suicide cancer gene therapy. J
Gene Med. 11:373–381. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ren C, Kumar S, Chanda D, Chen J, Mountz
JD and Ponnazhagan S: Therapeutic potential of mesenchymal stem
cells producing interferon-alpha in a mouse melanoma lung
metastasis model. Stem Cells. 26:2332–2338. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakamura K, Ito Y, Kawano Y, Kurozumi K,
Kobune M, Tsuda H, Bizen A, Honmou O, Niitsu Y and Hamada H:
Antitumor effect of genetically engineered mesenchymal stem cells
in a rat glioma model. Gene Ther. 11:1155–1164. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhong XG, He S, Yin W, Deng JY and Cheng
B: Selective tropism of liver stem cells to hepatocellular
carcinoma in vivo. World J Gastroenterol. 13:3886–3891. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen XC, Wang R, Zhao X, Wei YQ, Hu M,
Wang YS, Zhang XW, Zhang R, Zhang L, Yao B, et al: Prophylaxis
against carcinogenesis in three kinds of unestablished tumor models
via IL12-gene-engineered MSCs. Carcinogenesis. 27:2434–2441. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao Y, Yao A, Zhang W, et al: Human
mesenchymal stem cells overexpressing pigment epithelium-derived
factor inhibit hepatocellular carcinoma in nude mice. Oncogene.
29:2784–2794. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aquino JB, Bolontrade MF, García MG,
Podhajcer OL and Mazzolini G: Mesenchymal stem cells as therapeutic
tools and gene carriers in liver fibrosis and hepatocellular
carcinoma. Gene Ther. 17:692–708. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiao L, Xu Z, Zhao T, et al: Suppression
of tumorigenesis by human mesenchymal stem cells in a hepatoma
model. Cell Res. 18:500–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiao L, Zhao TJ, Wang FZ, Shan CL, Ye LH
and Zhang XD: NF-kappaB downregulation may be involved the
depression of tumor cell proliferation mediated by human
mesenchymal stem cells. Acta Pharmacol Sin. 29:333–340. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Campos B, Wan F, Farhadi M, Ernst A,
Zeppernick F, Tagscherer KE, Ahmadi R, Lohr J, Dictus C, Gdynia G,
et al: Differentiation therapy exerts antitumor effects on
stem-like glioma cells. Clin Cancer Res. 16:2715–2728. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Omar HA, Sargeant AM, Weng JR, Wang D,
Kulp SK, Patel T and Chen CS: Targeting of the Akt-nuclear
factor-kappaB signaling network by
[1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol
(OSU-A9), a novel indole-3-carbinol derivative, in a mouse model of
hepatocellular carcinoma. Mol Pharmacol. 76:957–968. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu LF, Li GP, Su JD, Pu ZJ, Feng JL, Ye YQ
and Wei BL: Involvement of NF-kappaB activation in the apoptosis
induced by extracellular adenosine in human hepatocellular
carcinoma HepG2 cells. Biochem Cell Biol. 88:705–714. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim MO, Moon DO, Kang CH, Kwon TK, Choi YH
and Kim GY: beta-Ionone enhances TRAIL-induced apoptosis in
hepatocellular carcinoma cells through Sp1-dependent upregulation
of DR5 and downregulation of NF-kappaB activity. Mol Cancer Ther.
9:833–843. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ren K, Zhang W, Shi Y and Gong J: Pim-2
activates API-5 to inhibit the apoptosis of hepatocellular
carcinoma cells through NF-kappaB pathway. Pathol Oncol Res.
16:229–237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cho HA, Park IS, Kim TW, Oh YK, Yang KS
and Kim JS: Suppression of hepatitis B virus-derived human
hepatocellular carcinoma by NF-kappaB-inducing kinase-specific
siRNA using liver-targeting liposomes. Arch Pharm Res.
32:1077–1086. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fei HR, Chen G, Wang JM and Wang FZ:
Perifosine induces cell cycle arrest and apoptosis in human
hepatocellular carcinoma cell lines by blockade of Akt
phosphorylation. Cytotechnology. 62:449–460. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Buontempo F, Ersahin T, Missiroli S,
Senturk S, Etro D, Ozturk M, Capitani S, Cetin-Atalay R and Neri
ML: Inhibition of Akt signaling in hepatoma cells induces apoptotic
cell death independent of Akt activation status. Invest New Drugs.
29:1303–1313. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nair AS, Shishodia S, Ahn KS, Kunnumakkara
AB, Sethi G and Aggarwal BB: Deguelin, an Akt inhibitor, suppresses
IkappaBalpha kinase activation leading to suppression of
NF-kappaB-regulated gene expression, potentiation of apoptosis and
inhibition of cellular invasion. J Immunol. 177:5612–5622. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR,
Pfeffer LM and Donner DB: NF-kappaB activation by tumour necrosis
factor requires the Akt serine-threonine kinase. Nature. 401:82–85.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsao MS, Smith JD, Nelson KG and Grisham
JW: A diploid epithelial cell line from normal adult rat liver with
phenotypic properties of 'oval' cells. Exp Cell Res. 154:38–52.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin HH, Chen JH, Chou FP and Wang CJ:
Protocatechuic acid inhibits cancer cell metastasis involving the
down-regulation of Ras/Akt/NF-kappaB pathway and MMP-2 production
by targeting RhoB activation. Br J Pharmacol. 162:237–254. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park YP, Choi SC, Kim BY, Kim JT, Song EY,
Kang SH, Yoon DY, Paik SG, Kim KD, Kim JW and Lee HG: Induction of
Mac-2BP by nerve growth factor is regulated by the
PI3K/Akt/NF-kappaB-dependent pathway in the HEK293 cell line. BMB
Rep. 41:784–789. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yuki K, Hirohashi S, Sakamoto M, Kanai T
and Shimosato Y: Growth and spread of hepatocellular carcinoma. A
review of 240 consecutive autopsy cases. Cancer. 66:2174–2179.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Genda T, Sakamoto M, Ichida T, Asakura H,
Kojiro M, Narumiya S and Hirohashi S: Cell motility mediated by rho
and Rho-associated protein kinase plays a critical role in
intrahepatocytic metastasis of human hepatocellular carcinoma.
Hepatology. 30:1027–1036. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li L and Neaves WB: Normal stem cells and
cancer stem cells: The niche matters. Cancer Res. 66:4553–4557.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, Ren
N, Jia HL, Shi J, Wu JC, Dai C, et al: Human mesenchymal stem cells
inhibit metastasis of a hepatocellular carcinoma model using the
MHCC97-H cell line. Cancer Sci. 101:2546–2553. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Karin M, Cao Y, Greten FR and Li ZW:
NF-kappaB in cancer: From innocent bystander to major culprit. Nat
Rev Cancer. 2:301–310. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Haefner B: NF-kappaB: Arresting a major
culprit in cancer. Drug Discov Today. 7:653–663. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Testa JR and Bellacosa A: AKT plays a
central role in tumorigenesis. Proc Natl Acad Sci U S A.
98:10983–10985. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cheng JQ, Lindsley CW, Cheng GZ, Yang H
and Nicosia SV: The Akt/PKB pathway: Molecular target for cancer
drug discovery. Oncogene. 24:7482–7492. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wendel HG, De Stanchina E, Fridman JS,
Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J and Lowe SW:
Survival signalling by Akt and eIF4E in oncogenesis and cancer
therapy. Nature. 428:332–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Clark AS, West K, Streicher S and Dennis
PA: Constitutive and inducible Akt activity promotes resistance to
chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol
Cancer Ther. 1:707–717. 2002.PubMed/NCBI
|
|
41
|
Li Y, Ahmed F, Ali S, Philip PA, Kucuk O
and Sarkar FH: Inactivation of nuclear factor kappaB by soy
isoflavone genistein contributes to increased apoptosis induced by
chemotherapeutic agents in human cancer cells. Cancer Res.
65:6934–6942. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Konrath F, Witt J, Sauter T and Kulms D:
Identification of new IκBα complexes by an iterative experimental
and mathematical modeling approach. PLoS Comput Biol.
10:e10035282014. View Article : Google Scholar : PubMed/NCBI
|
